Respiratory syncytial virus (RSV) vaccine choices during pregnancy

Bing Wang1, Prabha Andraweera1, Gang Chen2

  • 1Vaccinology and Immunology Research Trials Unit, Women's and Children's Health Network, Adelaide, South Australia, Australia; Robinson Research Institute and Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.

Public Health
|January 8, 2026
PubMed

Insights

Australian pregnant women prefer free maternal Respiratory Syncytial Virus (RSV) vaccines, prioritizing safety and effectiveness. Preferences for promotion strategies varied among vaccine accepters and rejecters.

Area of Science:

  • Public Health
  • Vaccinology
  • Maternal and Child Health

Background:

  • Respiratory Syncytial Virus (RSV) is a major cause of infant respiratory illness.
  • New maternal RSV vaccines and infant monoclonal antibodies offer protection.
  • Understanding vaccine attitudes in pregnant populations is crucial for public health strategies.

Purpose of the Study:

  • To assess Australian pregnant women's attitudes towards maternal RSV vaccination.
  • To identify factors influencing decisions regarding RSV vaccination in pregnancy.
  • To compare preferences between maternal vaccination and infant monoclonal antibody administration.

Main Methods:

  • A cross-sectional online survey with a discrete choice experiment (DCE) design was used.
  • Focus group discussions informed the DCE survey development.
  • Mixed logit and latent class models analyzed survey data from 440 participants.

Main Results:

  • Pregnant women strongly preferred a free maternal RSV vaccine with high effectiveness and low side effect risk.
  • Two preference groups emerged: 'accepters/deliberators' (68.3%) and 'rejecters' (31.7%).
  • Maternal RSV vaccination was significantly preferred over infant monoclonal antibodies (54.8% vs. 16.8%).

Conclusions:

  • Maternal RSV vaccination is generally well-received by pregnant women when offered at no cost.
  • Preference for promotional strategies differed between vaccine accepters and rejecters.
  • Targeted communication strategies may be necessary to address varied attitudes towards RSV vaccination.
Abstract

Related Concept Videos

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
951
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
1.3K
Vaccinations01:51

Vaccinations

Overview
51.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
1.1K
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
806